Alison Rankin Buys Shares of HY
Alison Rankin purchased 20 shares of HY, reflecting ongoing insider activity.
Key Points
- Alison Rankin purchased 20 shares of HY at $38.3 each on June 15, 2026, for a total value of $766.
- Shares of HY traded near $37.55, with significant institutional activity from BlackRock and Vanguard.
- Analysts from Roth MKM and Northland reiterated buy ratings with price targets of up to $90.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 15, 2026, Alison Rankin purchased 20 shares of HY at an average price of $38.3 per share, totaling $766. This transaction adds to the ongoing insider activity at the company.
Insider Buying and Selling at Hyster-Yale, Inc.
Alison Rankin's recent purchase of 20 shares at $38.3 each wasn't part of a pre-arranged trading plan. The same day saw other insiders, including Elisabeth Rankin and Alfred Rankin, each involved in similar transactions, but they were sellers. This activity highlights a range of insider trading actions within HY.
Other Institutional Activity in HY
Several institutional investors have made moves in HY recently. BlackRock, Inc. increased its holdings by 17,635 shares, bringing its total to 908,512 shares valued at approximately $29.5 million. Dimensional Fund Advisors LP also added 28,642 shares, ending with 587,683 shares worth about $19.1 million. Meanwhile, Vanguard Capital Management LLC initiated a new position with 475,791 shares, valued at around $15.5 million. Conversely, Gamco Investors, Inc. reduced its stake by 23,309 shares, leaving it with 811,057 shares valued at $26.4 million.
Hyster-Yale, Inc. Stock Up 10.5%
Shares of HY are trading around $37.55. The company has seen significant interest from both insiders and institutions, which could impact its market dynamics. With ongoing analyst support and substantial institutional investments, HY remains a stock to watch.
Analysts Set New Price Targets
Analysts remain optimistic about HY's prospects. On June 7, 2024, Roth MKM reiterated its buy rating with a price target of $87. Earlier, on June 5, 2024, Northland maintained its buy rating with a $90 target. These targets reflect confidence in HY’s potential, supported by a consensus recommendation leaning towards a buy.
Bottom Line
Alison Rankin's recent purchase of HY shares is part of a broader pattern of insider and institutional activity. While insider actions can provide insights into management's outlook, it's important to consider them alongside analyst ratings and institutional moves. Investors should note that these transactions are historical and may not reflect current positions.
Get Hyster-Yale, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HY, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.